BTIG Announces Expansion of Healthcare Research – Tim Chiang to Launch Specialty Pharmaceutical Research Coverage

New York – May 13, 2015 – BTIG, LLC, a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services, announced today that Tim Chiang has joined the firm as a Managing Director and Specialty Pharmaceutical Research Analyst.

Mr. Chiang has more than 20 years of experience in the pharmaceutical sector, having worked within major pharmaceutical companies and analyzing companies within the sector for several global financial services firms. At BTIG, Mr. Chiang’s coverage will focus on specialty pharmaceutical companies, stocks, trends and the competitive landscape. Specialty pharmaceutical research represents a new sector of coverage for BTIG, an important addition to the firm’s growing healthcare research offering.

“We are extremely pleased that Tim is joining us to further strengthen our Healthcare Research team. Complementing the rapidly expanding healthcare research coverage universe of our other team members, Mr. Chiang will greatly enhance BTIG’s expertise in the sector,” said Karen Blando, Managing Director and Director of Research at BTIG. “With his broad network of relationships and deep understanding of the specialty pharmaceutical space, our clients will value his prescient perspective and actionable market intelligence.”

Prior to joining BTIG, Mr. Chiang was a Managing Director and Senior Analyst at CRT Capital Group for the past five years. He held similar positions at FTN Midwest Research and Natexis Bleichroeder, and was part of the Specialty Pharmaceutical Research Team at Banc of America Securities and UBS Securities. In 2012, he was named the top stock picker in the Pharmaceutical sector by the Financial Times and Thomson Reuters’ StarMine Analyst Awards. Mr. Chiang holds a B.A. in Economics from Northwestern University and an MBA from Carnegie Mellon University. Prior to entering the financial services sector, he worked at Abbott Laboratories and Merck. He is frequently quoted by major financial news media outlets, and has appeared on CNBC, Bloomberg and Reuters TV.

Mr. Chiang’s hire signals another milestone for BTIG as it continues to build out its research offering. Expanding its research coverage through launching of new sectors and industries is a key priority for the firm as it continues to identify top-tier talent that meets the demand of an ever-evolving global client base.

About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 475 employees, BTIG, LLC and its affiliates operate out of 13 cities in North America, Europe and Asia Pacific. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs, fixed income, futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities. The company’s core capabilities include global sales, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Media Contacts:
Jill Gordon
212.279.3115, ext. 226
[email protected]

Amanda Gold
212.738.6134
[email protected]

Disclaimer: https://www.btig.com/disclaimer